Home › Schizophrenia › New York
Schizophrenia clinical trials in New York
23 studies for Schizophrenia are looking for participants at sites in New York.
Cities in New York
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Neurobehavioral Research Inc, Cedarhurst
- Evolution Research Group, Staten Island
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 28, 2026 · NCT07615426Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, The Bronx
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07227818NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
- and 2 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- NYU Child Study Center, New York
- Richmond Behavioral Associates, Staten Island
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Harlem, New York
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0061, Great Neck
- Local Institution - 0156, Staten Island
- Local Institution - 0151, The Bronx
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT0742440452-week Open Label Safety-Tolerability Study
- Neuro-Behavioral Clinical Research, New York
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0061, Great Neck
RecruitingPhase 3
Ages 13 to 17 · All sexes · Updated Sep 4, 2026 · NCT07288567A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, New York
- Clinical Site, Staten Island
- Clinical Site, The Bronx
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Radial - Manhattan, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07101094Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0037, Buffalo
- Local Institution - 0004, Monsey
- Local Institution - 0038, Rochester
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, New York
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 14, 2026 · NCT05303064Biomarkers to Enhance Early Schizophrenia Treatment
- Feinstein Institute for Medical Research, Glen Oaks
RecruitingPhase 4
Ages 18 to 35 · All sexes · Updated Jul 31, 2026 · NCT06969755MicroRNAs as Biomarkers in First Episode Schizophrenia
- Zucker Hillside Hospital, Glen Oaks
RecruitingHealthy volunteers welcome
Ages 15 to 40 · All sexes · Updated Jul 14, 2026 · NCT07703670A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
- Manhattan Psychiatric Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division, White Plains
Recruiting
Ages 18 to 64 · All sexes · Updated Jun 10, 2026 · NCT07434479Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- NYU Langone Medical Center, New York
- New York State Psychiatric Institute, New York
- Manhattan Psychiatric Center, New York
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated May 4, 2026 · NCT05208190NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Staten Island
- Neurocrine Clinical Site, The Bronx
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Staten Island
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5108, New York
- Site 5077, New York
- Site 5126, White Plains
RecruitingPhase 2
Ages 21 to 55 · All sexes · Updated Dec 26, 2025 · NCT06502964Visual Perception in Schizophrenia
- University of Rochester, Rochester
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 12, 2025 · NCT06911931Effectiveness of Motivation Skills Training (MST)
- The Bridge, Inc., New York
- New York State Office of Mental Health, New York
Recruiting
Ages 18 to 65 · All sexes · Updated Nov 5, 2025 · NCT05805397Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
- Zucker Hillside Hospital, New York
Recruiting
Ages 18 to 60 · All sexes · Updated Sep 25, 2025 · NCT05389787iTBS to Enhance Social Cognition in People With Psychosis
- Zucker Hillside Hospital, Glen Oaks
Recruiting
Ages 18 to 39 · All sexes · Updated May 22, 2025 · NCT06118268From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.